Deals & Corporate Governance

  • January 16, 2024

    Union Funds Drop Suit Against CIA Janitorial Contractors

    Two union benefit funds have dropped their federal lawsuit against a pair of companies that staff janitorial workers and security guards at the Central Intelligence Agency's headquarters, agreeing in a stipulation of dismissal docketed Tuesday to stop pursuing claims that the companies withheld financial documents from fund-retained auditors.

  • January 16, 2024

    Crowell Adds Moses Singer Health Trio In New NYC Office

    Crowell & Moring LLP announced Tuesday that it has hired a team from Moses & Singer LLP with rare expertise in regulatory and compliance issues related to clinical trials for biotech and health tech companies.

  • January 12, 2024

    UPenn Health System Eyes Merger With Ailing Hospital

    The University of Pennsylvania Health System has announced plans to acquire Doylestown Health in a deal that aims to increase its competitive footprint in the Philadelphia area.

  • January 12, 2024

    Taxation With Representation: Kirkland, Latham, Wachtell

    In this week's Taxation With Representation, Chesapeake Energy and Southwestern Energy announce a merger, Hewlett Packard Enterprise acquires Juniper Networks, Johnson & Johnson buys Ambrx Biopharma Inc., and Boston Scientific Corp. purchases Axonics Inc.

  • January 11, 2024

    2nd Circ. Hears UnitedHealth Office-Based Surgery Fight

    A Second Circuit panel was told Thursday that a lower court erred when it found UnitedHealth Group Inc. and related companies didn't violate federal benefits law by not paying facility fees to out-of-network, office-based surgery providers.

  • January 11, 2024

    Wash. Justice Flags Class Action 'Weakness' In Wage Claim

    Washington's high court debated Thursday whether U.S. Supreme Court precedent on class actions required the revival of a nurse's wage-theft suit, with one justice noting a "weakness" in the case because it was not itself a class action.

  • January 11, 2024

    Activist Firm Sets Off Board Challenge At Healthcare REIT

    Hedge fund Land & Buildings Investment Management LLC has nominated three candidates to healthcare real estate investment trust Ventas Inc.'s board of directors, the REIT said Thursday, which kicks off a fight for power at a company Land & Buildings has leveled criticism at for over two years.

  • January 11, 2024

    Medtech Co. Integer To Buy Pulse Technologies For $140M

    Medical device manufacturer Integer Holdings Corp. announced Wednesday that it has acquired private engineering and contract manufacturing company Pulse Technologies Inc. for around $140 million.

  • January 10, 2024

    Union Funds Exit Amgen, Teva Antitrust MDL

    Teva Pharmaceuticals has settled its differences with the union funds making up the indirect purchase class in multidistrict litigation accusing it of hatching an illegal deal to remove a generic calcium-control drug from the market.

  • January 10, 2024

    US Trustee Calls SmileDirect Ch. 11 Deal An Improper Plan

    The Office of the United States Trustee objected Wednesday to a global settlement proposed by bankrupt teledentistry company SmileDirectClub Inc., saying it amounts to an impermissible sub rosa plan that wouldn't cover the administrative costs of the Chapter 11 case prior to its dismissal.

  • January 10, 2024

    CNS Startup Myrobalan Therapeutics Raises $24M Series A

    Biotech company Myrobalan Therapeutics announced Wednesday it has raised a $24 million series A to develop treatments for degenerative CNS conditions.

  • January 09, 2024

    FTC Blocked IQVIA On Old Threshold, Without 'Rubber Stamp'

    The judge who temporarily blocked the merger between healthcare data company IQVIA and Propel Media shortly before it was abandoned insisted in his newly published federal court ruling that his decision wasn't a "rubber stamp" of the Federal Trade Commission's request to halt the deal.

  • January 09, 2024

    VC Firm Expands Collaborations In New Tech Initiative Debut

    Biotech venture capital firm Flagship Pioneering announced expanded collaborations with Samsung C&T Corp. and Thermo Fisher Scientific Inc. on Monday, as part of a larger initiative focused on fostering "enabling technologies" for the life sciences, during the J.P. Morgan Healthcare Conference in San Francisco.

  • January 09, 2024

    Biopharma Co. Can't Dodge Secrets Row Over Detox Drug

    A Florida federal judge has refused to throw out a suit from GBB Drink Lab Inc. claiming FSD Biosciences flouted a nondisclosure agreement relating to a blood-alcohol detoxification product.

  • January 09, 2024

    GSK Agrees To Buy US Respiratory Drug Biz For Up To $1.4B

    GSK said Tuesday that it has agreed to buy Aiolos Bio Inc., a clinical-stage asthma drug developer, in a deal that could reach $1.4 billion as the British pharmaceuticals giant looks to grow its portfolio of respiratory treatments.

  • January 08, 2024

    Merck Lands Cancer Fighter Harpoon Therapeutics For $680M

    Merck has entered into an agreement to acquire Harpoon Therapeutics, a cancer immunotherapy company founded eight years ago, for $23 per share in cash for an approximate total equity value of $680 million, the companies said Monday.

  • January 08, 2024

    Novartis To Buy Merck Spin-Off Calypso Biotech For Up To $375M

    Swiss pharmaceutical giant Novartis is buying European company Calypso Biotech in a deal that could be worth up to $375 million, according to an announcement from Calypso on Monday, marking one of the earliest deals to be announced at the start of the deal frenzy expected at the J.P. Morgan Healthcare conference in San Francisco this week.

  • January 08, 2024

    Eli Lilly, Novartis Could Pump Close To $3B Into AI Drug Tech

    Eli Lilly & Co. and Novartis could invest close to $3 billion in the development of artificial intelligence for drug discovery under two new agreements with a digital biology company owned by Google's parent company.

  • January 08, 2024

    Cravath Steers J&J Buy Of Skadden-Led Ambrx In $2B Deal

    Pharmaceutical industry giant Johnson & Johnson, advised by Cravath Swaine & Moore LLP, is buying San Diego, California-based clinical-stage biopharmaceutical company Ambrx Biopharma Inc., advised by Skadden Arps Slate Meagher & Flom LLP, in an all-cash, take-private deal with a total equity value of roughly $2 billion, the two companies announced separately Monday.

  • January 05, 2024

    Pharma Co. Snags $100M To Advance Psychedelic Treatment

    The pharmaceutical arm of the nonprofit Multidisciplinary Association for Psychedelic Studies said on Friday it raised $100 million in an initial round of financing as it transitions to new leadership.

  • January 05, 2024

    ​​Boehringer Ingelheim Inks €410M Deal With Kyowa Kirin

    Pharmaceutical giant Boehringer Ingelheim announced Friday that it had entered into a €410 million ($449 million) licensing agreement with Japanese pharmaceutical company Kyowa Kirin to develop a new treatment for fibro-inflammatory diseases, the third in a string of consecutive deals Boehringer Ingelheim has announced this week.

  • January 05, 2024

    Md. Retirees Ask 4th Circ. For 2nd Shot At Drug Coverage Suit

    Retired Maryland state employees have asked the Fourth Circuit for another chance to pursue a proposed class action over the state's transition of their prescription coverage plan to Medicare Part D after their first try was dismissed last year.

  • January 05, 2024

    9th Circ. Won't Rethink FCA Disclosure Ruling Against Valeant

    A Ninth Circuit panel on Friday denied drugmaker Valeant Pharmaceuticals' request to review its decision to revive a False Claims Act suit accusing Valeant of fraudulently obtaining a patent to extend its monopoly on the drug Apriso.

  • January 05, 2024

    Attys Hopeful For Deals Pickup As JPMorgan Event Kicks Off

    Attorneys heading to the annual J.P. Morgan Healthcare Conference are hoping to strike fruitful conversations with other dealmakers regarding capital-raising and M&A prospects, aided by the backdrop of several blockbuster acquisitions in recent weeks.

  • January 05, 2024

    NC Residents Bemoan Holdups In Hospital Monopoly Case

    A group of North Carolina residents are pushing the state Business Court to move ahead with discovery in their antitrust suit against Mission Hospital and its new owners, saying the case shouldn't have to idle while they wait for a long-delayed ruling in parallel federal litigation.

Expert Analysis

  • Avoiding Antitrust Enforcement In Health Care Joint Ventures

    Author Photo

    Considering the Federal Trade Commission's recent activity in challenging hospital combinations, health care companies must be mindful of antitrust considerations unique to the industry, and employ strategies to minimize enforcement risks, say attorneys at Holland & Knight.

  • Murdaugh Trials Offer Law Firms Fraud Prevention Reminders

    Author Photo

    As the fraud case against Alex Murdaugh continues to play out, the evidence and narrative presented at his murder trial earlier this year may provide lessons for law firms on implementing robust internal controls that can detect and prevent similar kinds of fraud, say Travis Casner and Helga Zauner at Weaver and Tidwell.

  • Check Onboarding Docs To Protect Arbitration Agreements

    Author Photo

    The California Court of Appeal's recent Alberto v. Cambrian Homecare decision opens a new and unexpected avenue of attack on employment arbitration agreements in California — using other employment-related agreements to render otherwise enforceable arbitration agreements unenforceable, say Morgan Forsey and Ian Michalak at Sheppard Mullin.

  • Firm Tips For Helping New Lawyers Succeed Post-Pandemic

    Author Photo

    Ten steps can help firms significantly enhance the experience of attorneys who started their careers in the coronavirus pandemic era, including facilitating opportunities for cross-firm connection, which can ultimately help build momentum for business development, says Lana Manganiello at Equinox Strategy Partners.

  • Fla. Foreign Real Estate Law Brings Broad Investment Risks

    Author Photo

    Last month, Florida became the latest state to enact legislation prohibiting Chinese investors from acquiring certain interests in real property, introducing significant legal uncertainty and consequences for real estate stakeholders and the private equity industry, say attorneys at Simpson Thacher.

  • Tackling Judge-Shopping Concerns While Honoring Localism

    Author Photo

    As the debate continues over judge-shopping and case assignments in federal court, policymakers should look to a hybrid model that preserves the benefits of localism for those cases that warrant it, while preventing the appearance of judge-shopping for cases of a more national or widespread character, says Joshua Sohn at the U.S. Department of Justice.

  • How Attorneys Can Help Combat Anti-Asian Hate

    Author Photo

    Amid an exponential increase in violence against Asian American and Pacific Islander communities, unique obstacles stand in the way of accountability and justice — but lawyers can effect powerful change by raising awareness, offering legal representation, advocating for victims’ rights and more, say attorneys at Gibson Dunn.

  • Congress Needs To Enact A Federal Anti-SLAPP Statute

    Author Photo

    Although many states have passed statutes meant to prevent individuals or entities from filing strategic lawsuits against public participation, other states have not, so it's time for Congress to enact a federal statute to ensure that free speech and petitioning rights are uniformly protected nationwide in federal court, say attorneys at Skadden.

  • Takeaways From New Fla. Pharmacy Benefit Manager Rules

    Author Photo

    A recently passed Florida law imposes several new requirements on pharmacy benefit managers, necessitating practical considerations that range from potential license application delays to possible trade secret exposure, say Thomas Range and Bruce Platt at Akerman.

  • Looking For Plausibility In FTC's Amgen Merger Challenge

    Author Photo

    The Federal Trade Commission is seeking to block Amgen's acquisition of Horizon, alleging that, if consummated, the deal would violate Section 7 of the Clayton Act — but this may be the first merger complaint in a generation that could be dismissed for failing to state a claim, say William MacLeod and David Evans at Kelley Drye.

  • Some Client Speculations On AI And The Law Firm Biz Model

    Author Photo

    Generative artificial intelligence technologies will put pressure on the business of law as it is structured currently, but clients may end up with more price certainty for legal services, and lawyers may spend more time being lawyers, says Jonathan Cole at Melody Capital.

  • A Lawyer's Guide To Approaching Digital Assets In Discovery

    Author Photo

    The booming growth of cryptocurrency and non-fungible tokens has made digital assets relevant in many legal disputes but also poses several challenges for discovery, so lawyers must garner an understanding of the technology behind these assets, the way they function, and how they're held, says Brett Sager at Ehrenstein Sager.

  • High Court's Ethics Statement Places Justices Above The Law

    Author Photo

    The U.S. Supreme Court justices' disappointing statement on the court's ethics principles and practices reveals that not only are they satisfied with a status quo in which they are bound by fewer ethics rules than other federal judges, but also that they've twisted the few rules that do apply to them, says David Janovsky at the Project on Government Oversight.